2 years ago

Chemify Secures $43 Million in Series A Funding to Advance Chemputation Technology

  • Chemify, a UK-based developer of chemputation technology, raised $43 million in Series A funding led by Triatomic Capital

  • The funding will be used to accelerate the development of Chemify's technology, which helps to reduce the amount of experimentation required to discover new molecules and speed up the development of products for medicine, farming, materials science, and green energy.

      • ProblemHealthcare

      "Chemify is addressing the challenge of reducing the time and resources required for discovering new molecules by streamlining the process through digital design and automation."

      Solution

      "Chemify's technology integrates chemistry research, robotics, and AI to facilitate the digital design, discovery, and manufacturing of complex molecules and materials, thus accelerating the development of new products across various industries."

      Covered on